Ubs Asset Management Americas Inc Bio Techne Corp Transaction History

Ubs Asset Management Americas Inc

$477 Billion
Q2 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 818,138 shares of TECH stock, worth $51.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

818,138

Previous 944,327 13.36%

Holding current value

$51.9 Million

Previous $55.4 Million 23.97%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$46.66 - $58.38 $5.89 Million - $7.37 Million	-126,189 Reduced 13.36%	818,138 $42.1 Million
Q1 2025 May 19, 2025	BUY	$58.47 - $78.75 $1.15 Million - $1.54 Million	19,606 Added 2.12%	944,327 $55.4 Million
Q4 2024 Feb 14, 2025	BUY	$66.37 - $78.17 $11.3 Million - $13.3 Million	170,377 Added 22.59%	924,721 $66.6 Million
Q3 2024 Nov 14, 2024	BUY	$70.96 - $82.35 $1.44 Million - $1.67 Million	20,277 Added 2.76%	754,344 $60.3 Million
Q2 2024 Aug 13, 2024	BUY	$62.12 - $84.15 $11.9 Million - $16.1 Million	191,096 Added 35.19%	734,067 $52.6 Million
Q1 2024 May 15, 2024	SELL	$65.98 - $77.09 $931,175 - $1.09 Million	-14,113 Reduced 2.53%	542,971 $38.2 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $19,018 - $28,159	360 Added 0.06%	557,084 $43 Million
Q3 2023 Nov 13, 2023	BUY	$67.52 - $89.42 $6.54 Million - $8.67 Million	96,922 Added 21.08%	556,724 $37.9 Million
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $15,541 - $18,796	-217 Reduced 0.05%	459,802 $34.1 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $27.6 Million - $121 Million	342,754 Added 292.29%	460,019 $38.1 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $4.9 Million - $6.8 Million	-17,354 Reduced 12.89%	117,265 $33.3 Million
Q2 2022 Aug 12, 2022	SELL	$322.67 - $449.65 $2.9 Million - $4.04 Million	-8,980 Reduced 6.25%	134,619 $46.7 Million
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $1.07 Million - $1.48 Million	3,029 Added 2.15%	143,599 $62.2 Million
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $1.25 Million - $1.44 Million	2,740 Added 1.99%	140,570 $72.7 Million
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $4.4 Million - $5.33 Million	9,897 Added 7.74%	137,830 $66.8 Million
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $18.3 Million - $21.3 Million	47,364 Added 58.79%	127,933 $57.6 Million
Q1 2021 May 14, 2021	BUY	$314.62 - $411.0 $185,940 - $242,901	591 Added 0.74%	80,569 $30.8 Million
Q4 2020 Mar 01, 2021	BUY	$246.9 - $321.87 $2.77 Million - $3.61 Million	11,204 Added 16.29%	79,978 $25.4 Million
Q3 2020 Nov 13, 2020	BUY	$232.22 - $282.96 $587,284 - $715,605	2,529 Added 3.82%	68,774 $17 Million
Q2 2020 Aug 14, 2020	BUY	$185.43 - $279.56 $2.4 Million - $3.62 Million	12,963 Added 24.33%	66,245 $17.5 Million
Q1 2020 May 15, 2020	BUY	$161.17 - $221.51 $909,965 - $1.25 Million	5,646 Added 11.85%	53,282 $10.1 Million
Q4 2019 Feb 14, 2020	SELL	$189.68 - $222.09 $45,333 - $53,079	-239 Reduced 0.5%	47,636 $10.5 Million
Q3 2019 Nov 14, 2019	BUY	$183.56 - $216.72 $573,257 - $676,816	3,123 Added 6.98%	47,875 $9.37 Million
Q2 2019 Aug 15, 2019	BUY	$188.72 - $215.43 $408,578 - $466,405	2,165 Added 5.08%	44,752 $0
Q1 2019 May 14, 2019	BUY	$136.09 - $200.44 $935,890 - $1.38 Million	6,877 Added 19.26%	42,587 $0
Q4 2018 Feb 13, 2019	BUY	$132.75 - $203.8 $27,612 - $42,390	208 Added 0.59%	35,710 $5.17 Million
Q3 2018 Nov 14, 2018	BUY	$147.44 - $204.11 $400,004 - $553,750	2,713 Added 8.27%	35,502 $0
Q2 2018 Aug 14, 2018	BUY	$144.9 - $165.58 $9,418 - $10,762	65 Added 0.2%	32,789 $0
Q1 2018 May 14, 2018	BUY	$131.46 - $151.04 $252,008 - $289,543	1,917 Added 6.22%	32,724 $0
Q4 2017 Feb 09, 2018	SELL	$121.17 - $134.75 $200,778 - $223,280	-1,657 Reduced 5.1%	30,807 $0
Q3 2017 Nov 13, 2017	BUY	$113.59 - $123.78 $3.69 Million - $4.02 Million	32,464	32,464 $0

Others Institutions Holding TECH

# of Institutions

613

Shares Held

161M

Call Options Held

225K

Put Options Held

80.8K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.49B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Bio Techne Corp Transaction History